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Introduction
Untreated obstructive sleep apnea has been strongly linked to 
many serious diseases and early mortality. It can be the underly-
ing cause of certain diseases, and it can cause rapid progression 
or early onset of others. Perhaps even more alarming, is that 
many incidences of sudden death, especially heart attacks, have 
been attributed to untreated obstructive sleep apnea. The basic 
understanding of its severity is that untreated obstructive sleep 
???????????????????????????????????????????????????????????????
This trauma is mainly due to nightly deprivation of oxygen in 
the blood, sleep deprivation, constant hyper stimulation of the 
sympathetic nervous system, and enormous strain on the heart. 
It is noteworthy that there are also secondary physical, mental, 
and emotional health concerns associated with untreated sleep 
apnea. In a random sample of several hundred individuals pre-
senting to a sleep clinic with symptoms typical of sleep apnea, 
it was observed that the vast majority of the patients subse-
quently diagnosed with obstructive sleep apnea had at least 
one other serious health issue. The percentage of people with 
additional health problems tended to be much higher among 
those 40 years of age and older- i.e. in the individuals who had 
gone through many more years of trauma to their bodies before 
seeking treatment (personal observation, Chang, et.al. 2013).
It is also especially critical to explore the effects of untreat-
ed sleep apnea because it effects many more people than was 
previously thought (up to 24% of adult men) (Peppard, et.al. 
2000) and because there has been a steady rise in the diagno-
sis of sleep apnea with the increased incidence of obesity. In 
addition to the obesity factor, it is now known that the general 
aging process is a major risk factor in the development of sleep 
apnea. Consequently, it may be prudent to study the diagnos-
tic methods and treatment options for sleep apnea for those 
involved in geriatric care (Adegunsoye, Ramachandran, 2012). 
Several studies indicate that post-menopausal women are at 
increased risk for developing obstructive sleep apnea because 
the female sex hormones which help dilate the airway decrease 
after menopause (Chang, et.al. 2013). This paper will explore the 
question of how untreated sleep apnea effects the body and the 
implications of these effects.
Methods
Relevant material was scoured mainly from the web, from con-
versations and correspondence with a veteran pulmonologist 
and sleep specialist, and from personal experience observing 
and interviewing patients and studying polysomnography data at 
a sleep clinic over a period of about two months. Only materials 
from authoritative sources were used. An effort was made to 
gather information on the interaction between sleep apnea and 
numerous medical conditions thus broadening the scope of the 
paper. This was done in order get as full a picture as possible on 
how sleep apnea may affect the body. Material on the effective-
ness of treatment of sleep apnea was also considered pertinent 
to understanding the mechanisms of this condition and are in-
cluded in the discussion accordingly.
?????????????????
???????????????????????????????????????????????????????????????
of ten seconds or more while asleep (Tsara, et.al. 2009). There 
are two main types of sleep apnea: Obstructive Sleep Apnea, and 
Central Sleep Apnea.
Obstructive Sleep Apnea (OSA): OSA is an anatomical condi-
tion where, while asleep, the muscles in the throat relax to an 
???????????????????????????????????????????????????????????????-
eral different muscles responsible for this. Sleep apnea is more 
common in people who have a narrow airway. A narrow airway 
???????????????? ???????????????????? ???????????????? ??????????
due to obesity. (Obese individuals often have excess submucosal 
adipose tissue which can build up around the airway thereby 
causing the airway to compress.) Defects in, or damage to, the 
face or neck in areas which affect the airway may also be a risk 
factor for OSA. OSA can affect adults or children, but is more 
common in adults (Tsara, et.al. 2009). OSA can be a factor in de-
termining the cause of Sudden Infantile Death Syndrome (SIDS), 
and a family history of OSA may be considered a risk factor in 
SIDS (Thach, 2008).
Central Sleep Apnea (CSA): CSA is a condition where the 
apneustic center in the brain stem fails to send nerve impulses 
necessary for breathing. CSA can occur without an obstruct-
ed airway. However, OSA and CSA are often clinically related. 
Abstract
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may be more common now with the increasing incidence of obesity and the growing number of elderly individuals in our popu-
lation. How serious is this condition, and what are the potential long-term effects and consequences of obstructive sleep apnea 
if left untreated?  An overlap of many serious conditions with obstructive sleep apnea has been noticed. These conditions include 
hypertension, heart disease and failure, stroke, diabetes, neurological diseases, depression, and a number of other serious health 
concerns. The purpose of this paper is to understand what the effects of untreated obstructive sleep apnea might be, and to 
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
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which can lead to high blood pressure and subsequent heart disease and failure, and by causing repeated episodes of unnatural 
????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????
that sleep apnea should not be viewed as an incidental condition alongside other serious health problems nor mainly as a side 
effect of them. It should rather be seen as a contributing factor, if not the primary cause, of many consequential health issues.
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When a patient who has CSA and OSA is treated just for the 
OSA, the CSA part of the sleep apnea is often minimized or 
even eliminated (Costanzo, et.al. 2015). It is possible that the 
disordered breathing caused by the OSA may contribute to the 
apneustic center malfunction- either directly or by a secondary 
mechanism. CSA can also be accompanied by irregular breath-
ing patterns. For example, the Cheyne-Stokes respiration is a 
common symptom of primary CSA (Tsara, et.al. 2009, Costanzo, 
et.al. 2015). (Cheyne-Stokes respiration is a breathing pattern 
where there are rapid or deep breaths followed by a decrease 
and secession of breathing. This is usually in a cycle which can 
last anywhere from 30 seconds to two minutes.) CSA can also 
be secondary to illness or trauma, and it can be caused by 
certain medications and substances. It is noteworthy that if a 
newborn has sleep apnea, it is often CSA (Tsara, et.al. 2009) and 
may be a factor in determining the cause of SIDS (Thach, 2008).
Hypopnea: A hypopnea is a partial closure of the airway which 
is often characterized by loud snoring. (The snoring is caused 
????????????????????????????????????????????????????????????????
????? ?????????? ????????????????? ???????? ???????? ??? ?????????? ???
a hypopnea when the obstruction is severe enough to cause 
oxygen desaturation in the blood.
Polysomnography: A polysomnography is a sleep study. During 
a sleep study, the individual is attached to electrodes and other 
machinery which collect information about the person’s sleep. 
This information will include how long the patient spent in each 
phase of sleep, whether or not the patient has OSA or CSA, ox-
ygen saturation or desaturation in the blood, breathing patterns, 
and many other items of relevance. A polysomnography can be 
used to diagnose sleep apnea.
Apnea-Hypopnea Index (AHI): An AHI is a score of how many 
events of apnea and hypopnea occur per hour. For example, if 
six times in the course of an hour, a patient stops breathing for 
ten seconds or more and/or has an oxygen desaturation, then 
the patient will have an AHI of 6 (or an event on average of 
every ten minutes).
Sleep Disordered Breathing: Sleep disordered breathing is a 
general term used to refer to any abnormal breathing issues 
or abnormal breathing patterns which can occur when one is 
asleep.
Continuous Positive Airway Pressure Machine (CPAP 
Machine): A CPAP Machine is a medical device which blows air 
through the nose to the back of the airway to keep it open while 
a person is asleep. It is currently the most effective standard 
treatment for sleep apnea. The machine can be adjusted to apply 
more or less pressure as needed, and modern machines are 
often self-adjusting. Other machines are available to treat more 
complicated cases, but they too incorporate positive pressure 
to treat the OSA component of any sleep disordered breathing. 
There are surgeries which can be performed to help eliminate 
OSA, but they are only about 50% effective. Some dental devices 
have been developed to treat OSA, but they too are often insuf-
???????????????????????????????????????????????????
Discussion
The most obvious area of concern with sleep apnea is the fact 
that when breathing stops, oxygen doesn’t enter the lungs. 
This, in turn, leads to oxygen desaturation in the blood. This 
hypoventilation has been linked to a number of conditions such 
as systemic hypertension (Peppard, et.al. 2000), pulmonary hy-
pertension (average pressure in the pulmonary arteries greater 
than 25mmHg (resting)) (Adegunsoye, Ramachandran, 2012), 
polycythemia (high red blood cell count), heart problems, be-
havioral issues, emotional issues (Sheu, et.al. 2015), and birth 
defects (Tsara, et.al. 2009, Adegunsoye, Ramachandran, 2012). 
It has also been reported that early treatment is effective in 
eliminating these negative effects, and it is therefore of para-
mount importance to recognize, diagnose, and treat sleep apnea 
syndrome at the earliest possible opportunity (Adegunsoye, 
Ramachandran, 2012).
Systemic hypertension can be due to numerous factors involv-
ing OSA. One factor is that the hypoxia may lead to a pressor 
effect as an attempt by the body to get more oxygen (Peppard, 
et.al. 2000, Tkacova, et.al. 2014). Another contributing factor to 
?????????????????????????????????????????????????????????????
nervous system activation of the renin angiotensin aldosterone 
system effecting the kidneys (Bradley, Floras, 2003, Nishizaka, 
et.al. 2004). Many patients with untreated OSA have swelling in 
their legs (personal observation). It is noteworthy that admin-
istration of oxygen does not prevent the hypertensive effect of 
untreated OSA (Leung, Bradley, 2001).
The increased risk for developing hypertension due to un-
treated OSA is present even in individuals diagnosed with mild 
sleep apnea (AHI of approx. 5) (Peppard, et.al. 2000). The risk 
for developing hypertension is, however, directly related to the 
severity of the sleep apnea. Several studies show that individu-
als with more severe sleep apnea were more likely to develop 
hypertension than those with milder sleep apnea (Peppard, et.al. 
2000, Peker, et.al. 2002, Nieto, et.al. 2000). The likelihood of de-
veloping hypertension is present regardless of gender, race, or 
ethnicity, and it is usually manifest in individuals middle age or 
older (Nieto, et.al. 2000). Severity of sleep apnea is based on AHI 
and on ODI (oxygen desaturation index) (Tkacova, et.al. 2014). 
If treatment for OSA is initiated before the onset of hyperten-
sion, then chronic hypertension as well as other cardiovascular 
disease may be avoided. Additionally, treatment for the OSA has 
a much greater impact on lowering blood pressure than does 
weight loss (Nieto, et.al. 2000, Tkacova, et.al. 2014, Lavie, et.al. 
2000). Even in the event that hypertension has already set in, 
???????????????????????????????? ??????????????????????????????-
imately 9 weeks of treatment (Milleron, et.al. 2004). The associ-
ation between sleep apnea and hypertension is so strong that 
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sleep apnea should be seriously considered in the diagnosis and 
treatment of high blood pressure (Lavie, et.al. 2000). 
Many studies have demonstrated that endothelial cells are 
severely damaged and impaired by hypoxic conditions, and 
the extent of endothelial cell damage has also been associated 
with the AHI index (Lui, et.al. 2013). The damage may occur in 
the form of apoptosis of endothelial cells, in the form of cell 
cycle arrest, and in a number of other ways which play a role in 
many of the adverse effects of untreated sleep apnea (Iida, et.al. 
2002). Endothelial cell damage and dysfunction is connected to 
????????????????????????????????????????????? ???????????????-
tion ability and nitric oxide production, and many other severe 
health issues (Bruno, et.al. 2013). Additionally, oxidative stress 
seems to be one of the main causes for endothelial cell damage. 
The extent of oxidative stress is likewise directly correlated to 
the severity of the sleep apnea (Del ben, et.al. 2012). It is ex-
tremely important to realize that the individual with untreated 
OSA is at increased risk of arterial stiffness, which can lead to 
heart disease and other severe health issues even if they expe-
rience very minimal symptoms (Kohler, et.al. 2008).
Hypoxia is known to cause an increase in reactive oxygen 
species. The mechanism for this phenomenon is not clear, but 
some studies suggest that this is due to the lack of a strong 
electron acceptor in the absence of oxygen. When there are no 
electron acceptors, the electrons have no place to go and there-
fore remain unbound as superoxide radicals or as other reac-
tive oxygen species (ROS) (Kondoh, et.al. 2013). Compounding 
this problem is the reperfusion following the apneic episode 
which also causes an increase in ROS. Reperfusion may cause 
an increase in ROS for two reasons. One is that cell function 
has been impaired due to the lack of oxygen and is altogether 
???????????????????????????????????????????????????????????????
??? ????? ???? ??????? ?????? ??? ??????? ?????????? ???? ???????????
cannot process it fast enough. Studies show that hypoxia and 
subsequent reperfusion can cause damage to the epithelial lin-
ing of blood vessels. This damage can cause and/or contribute to 
atherosclerosis (Sawatari, et.al. 2016).
Aside from the ROS caused by reperfusion, there are other 
ROS released by a number of granular leukocytes in response 
to hypoxemia. The increased presence of ROS is a general 
danger to the body and has been linked to cancer and other 
illnesses. This is especially a concern for cancers which originate 
in endothelial cells because they are most directly affected by 
ROS (Kondoh, et.al. 2013). This is especially the case when the 
body experiences this kind of oxidative stress night after night 
for years on end (Adegunsoye, Ramachandran, 2012, Milleron, 
et.al. 2004). Proper treatment of OSA solves the problem of 
oxidative stress and can help reverse some or all of the damage 
caused by it (Del ben, et.al. 2012, Bayram, et.al. 2009).
Pulmonary hypertension in particular, is one cause for right 
sided heart failure and has an especially grim prognosis if left 
untreated. Pulmonary hypertension can be caused by a number 
of conditions, but its link to OSA and general sleep disordered 
breathing is strong enough that the American College of Chest 
Physicians recommends that patients presenting with pulmo-
nary hypertension be evaluated for sleep disordered breathing. 
The pathophysiology of pulmonary hypertension in sleep dis-
ordered breathing is that the hypoxia caused by the breathing 
disorder in turn causes hypertrophy of the pulmonary arteries. 
This hypertrophy decreases perfusion of blood in the lungs. The 
situation is even more disastrous for individuals with emphy-
????????????????????????????? ?????????????????????????????????
the decrease in perfusion by working harder, and this attempted 
compensation puts enormous strain on the right ventricle. This 
strain is unsustainable and leads to right sided heart failure and a 
subsequent general dyspnea even at rest. If left untreated, death 
typically occurs within three years of diagnosis (Adegunsoye, 
Ramachandran, 2012). The mechanism of how hypoxia causes 
the initial hypertrophy of the pulmonary arteries needs elucida-
tion, but it seems to be related to endothelial cell dysfunction. 
(It is also noteworthy that obese individuals are more likely 
to develop pulmonary hypertension with OSA (Adegunsoye, 
Ramachandran, 2012).) 
Aside from hypertrophy of the pulmonary arteries which 
can cause pulmonary hypertension, there is the direct effect 
of hypoxia in the form of pulmonary vasoconstriction. The rea-
son for vasoconstriction during an hypoxic event is due to an 
attempt by the body to keep ventilation and perfusion in sync. 
In the absence of oxygen, vasoconstriction will lessen perfusion. 
This, however, will also cause an increase in pulmonary artery 
pressure. This pressure is primarily a concern while the individ-
ual is sleeping. However, about 20% of patients with elevated 
pulmonary artery pressure while sleeping will eventually devel-
op pulmonary hypertension even while awake. This may be be-
cause the increased blood pressure can directly cause damage 
to blood vessels and result in the hardening and stenosis of 
those damaged vessels.
Another area of concern in untreated OSA is the effect of 
prolonged sympathetic nervous system stimulation. When 
a person with OSA has an event, the body responds to the 
???????????????????????????????????????????????????????????????
This occurs for each event- all night, every night. One effect of 
this stimulation is vasoconstriction and an increased heart rate- 
both of which raise blood pressure. Eventually, this can lead to 
chronic systemic and pulmonary hypertension (Adegunsoye, 
Ramachandran, 2012).
Chronic systemic hypertension is known to negatively affect 
cardiovascular health and increase mortality. It has also been 
reported that hypertension in individuals with untreated OSA is 
????????????????????????????????????????????????????????????????????
the high blood pressure, beta blockers are the most effective, 
suggesting that a major contributing factor to the high blood 
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pressure is sympathetic stimulation (Leung, Bradley, 2001).
Even in the absence of chronic hypertension development, 
there is, concern of vascular endothelial dysfunction. Over-
stimulation of the sympathetic nervous system can, in of itself, 
lead to vascular endothelial dysfunction. The pathophysiology of 
the damage is, similar to what is found in patients with chronic 
hypertension: Vasoconstriction creates more resistance in the 
blood vessels. Resistance, especially if prolonged, can cause 
damage to the vasculature and lead to hardening of the blood 
vessels (Adegunsoye, Ramachandran, 2012). The damage can 
??????????????????????????????????????????????????????????????
over-stimulation linger into the wake hours as well (Tkacova, 
et.al. 2014).
The constant presence of catecholamine levels also puts the 
untreated OSA patient at greater risk for thromboembolism 
because high levels of catecholamines tends to lead to platelet 
aggregation. This and other phenomena which can predispose 
an individual to thromboembolism can be reversed with effec-
tive treatment. The reversal of which suggests that the hyperco-
agulability in individuals with OSA is indeed caused by the OSA 
(Adegunsoye, Ramachandran, 2012).
There is a secondary problem associated with untreated OSA 
of the sleep deprived individual. The way the body clears the 
obstructed breathing is by jolting the person out of deep sleep 
long enough to return muscle tone to the airway and open it 
back up.  This arousal from deep sleep is called a Respiratory 
Effort- Related Arousal or RERA. A RERA can be present even 
????????????????????????????????????????????????????????????????
breathing stops for less than 10 seconds, or if there is no sig-
??????????????????????????????????????????????????????????????????
There are serious health risks associated with sleep deprivation 
as well as physiological effects and secondary risks. Psychological 
effects could include depression, apathy, and irritably. Secondary 
risks could include general fatigue or falling asleep while driving 
(Adegunsoye, Ramachandran, 2012).
Sleep deprivation and hypoxia are both known causes of in-
??????????????????????????????????????????????????????????-
lial cell dysfunction and has also been linked to certain cancers 
????????????????????????????????????????????????????????????????
found in high levels in individuals with untreated OSA. Proper 
?????????? ??? ?????????? ??? ????????? ???? ???????????? ?????????
(Adegunsoye, Ramachandran, 2012, Shamsuzzaman, et.al. 2003).
Another factor associated with OSA which causes sleep 
deprivation is nocturia. Nocturia is a condition where an indi-
vidual’s sleep is interrupted multiple times in order to empty the 
bladder. The pathophysiology of this condition is that attempt-
ing to breathe with an obstructed airway causes an enormous 
amount of intrathoracic pressure which results in a much larger 
than usual volume of blood to enter the heart. In some individu-
?????????????????????????????????????????????????????????????????????
(ANP). ANP in turn causes the kidneys to excrete more water. 
?????????????????????????????????????????????????????????????????
blood in the heart mimics the mechanics of increased blood 
volume. Increased blood volume increases blood pressure. As a 
result, the body, thinking that it has too much blood, will want 
to get rid of the excess volume by way of diuresis (Umlauf, et.al. 
2004). Patients with OSA report that their nocturia subsides 
once they comply with effective treatment (Personal communi-
cation with patients).
In addition to the mimicking of increased blood volume which 
causes the release ANP, ANP excretion is also increased due to 
acidosis. The lack of oxygen caused by OSA can certainly lead to 
at least a temporary acidosis, and this may further contribute to 
nocturia. ANP also directly inhibits the excretion of vasopres-
sin. Vasopressin normally plays a role in the decrease in urine 
production while asleep. If vasopressin is inhibited, then urine 
production will not decrease and the individual may experience 
nocturia. In one study of carefully selected individuals diagnosed 
with OSA, blood levels of ANP, as well as urine levels of ANP and 
increased urine volume were directly correlated with untreated 
OSA. It is also noteworthy that an elevated level of blood ANP 
is related to mortality rates in patients with heart problems, and 
a correlation between heart disease and untreated OSA has 
been strongly established (Umlauf, et.al. 2004).
Nocturia is often associated with aging. This association is 
due to the general aging process, and in men due to prostate 
hypertrophy, and in women due to decreased bladder volume. 
Aging is also a risk factor for OSA, and as such, its another 
possible cause of the increase in nocturia with age in both men 
and women. The connection between untreated OSA and noc-
turia is one way to explain why, in many individuals, nocturia is 
not resolved with the treatment for benign prostate hypertro-
phy. It has also been documented that the incidence of sleep 
apnea doubles in women post menopause- probably as a result 
of low estrogen levels. This correlates well with the increase 
in nocturia in women post menopause. Attributing nocturia in 
post-menopausal women to untreated OSA may be more accu-
rate than attributing it to a simple decrease in bladder volume. 
??????????????????????? ?????????????????????????????????????????
?????????????????????????????????? ???????????????????????????
needs to be considered when evaluating the impact of nocturia 
(Umlauf, et.al. 2004).
Many individuals with OSA are obese. Obesity is a risk factor 
in OSA, but OSA can, in of itself, also cause weight gain. Weight 
gain can be attributed to lack of physical activity. People with 
OSA often experience chronic fatigue, and this can possibly 
cause OSA patients to limit their physical activity. However, in 
addition to this secondary cause for weight gain, OSA can be 
directly responsible for altered metabolic factors which lead 
to obesity. Leptin levels are often found to be at abnormally 
high levels in obese individuals. Patients with untreated OSA 
often have even higher levels of leptin than obese individuals. 
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The current understanding is that leptin is found at high lev-
els because of resistance to their appetite suppressing activity. 
Patients with untreated OSA have sometimes been found to 
have high levels of leptin and gain weight in the year prior to 
diagnosis, and these patients tend to return to normal leptin 
levels and lose the weight once proper treatment is undertaken. 
It is also noteworthy that a high leptin level is considered a risk 
factor for cardiovascular disease (Adegunsoye, Ramachandran, 
2012, Shamsuzzaman, et.al. 2003, Milleron, et.al. 2004).
Another metabolic factor linked to OSA is impaired glu-
cose tolerance. Insulin resistance has been directly correlated 
to OSA, and several studies demonstrate that individuals with 
OSA are several times more likely to develop diabetes mellitus 
than those without OSA (Adegunsoye, Ramachandran, 2012, 
Gottlieb, et.al. 2010, Bayram, et.al. 2009).
One of the most extensive areas of study concerning untreat-
ed OSA is the effect it has on the heart. In fact, about 50% of pa-
tients with heart failure have OSA, and medication for heart fail-
ure seems to have little, if no effect on alleviating OSA (Bradley, 
Floras, 2003). In addition to the effect of pulmonary hyperten-
sion on the heart (discussed above), there are additional ways in 
which untreated OSA can cause cardiac health problems. When 
the body tries to breath while the airway is obstructed, an enor-
mous amount of negative pressure is generated in the thoracic 
cavity. This negative pressure pulls large amounts of blood from 
the superior and inferior vena cava into the right atrium of 
the heart, thus effectively increasimg afterload (Shekerdemian, 
Bohn, 1999). The negative intrathoracic pressure increases ve-
nous return and distends the right ventricle which effectively 
? ??????????????????????????????????????????????????????? ?????????????
the negative pressure may prevent the left ventricle from re-
??????? ???? ??????? ????????? ??????????????? ??????? ?????????????
mechanisms effectively decrease cardiac output (Adegunsoye, 
Ramachandran, 2012, Mooe, et.al. 2001, Gottlieb, et.al. 2010). 
Individuals with OSA can thus have high blood pressure due to 
vasoconstriction from sympathetic nervous system stimulation 
but decreased cardiac output due to impaired left ventricular 
??????????????????????????????????????????????????????????????????
are also caused by this large negative pressure. This stress on 
the heart can cause either rapid or reduced heart rate, and 
even complete sudden heart failure. The longer the apneic ep-
isode the greater the risk of cardiac malfunction (Adegunsoye, 
Ramachandran, 2012).
?????????????????????????????????????????????????????????????
is also a risk for myocardial hypertrophy which can cause irre-
versible hypertension. The hypertrophy is caused by the con-
stant strain on the heart muscle- just as constant strain on any 
muscle leads to muscle growth. If the strain is primarily right 
sided, then the hypertrophy will affect the right side of the heart. 
If the strain is primarily left sided then it will affect the left side 
of the heart. If the strain is on both sides then the entire heart 
can be effected.  Hypertension caused by OSA can last beyond 
the actual apnea episodes, and even in the absence of myocardi-
al hypertrophy, this hypertension can last for many hours after 
awakening (Peppard, et.al. 2000, Peker, et.al. 2002). However, 
treatment for OSA can often reverse systemic and pulmonary 
hypertension if myocardial hypertrophy has not yet set in. This 
is one on the many reasons why it’s important to properly treat 
OSA at the earliest opportunity (Adegunsoye, Ramachandran, 
2012, Jean-louis et.al. 2010).
In addition to myocardial hypertrophy, there is concern 
that untreated OSA may cause ion channel remodeling in the 
heart. This condition can lead to sudden cardiac death (Chahal, 
Somers, 2016). Gene expression effecting potassium ion chan-
nels was studied by examining mRNA associated with potas-
???????????????????????????????????????????????????????????????
altering of several potassium pump genes which may result in an 
extended repolarization period. Potassium pumps are needed 
to pump positively charged potassium ions across the myocar-
dial cell membranes so that a new muscle contraction can begin. 
???????????????????????????????????????????????????????????????-
ization will take longer. One potential problem with this is that 
there is a danger of ventricular extrasystole (premature ven-
tricular contraction). This kind of arrhythmia can cause sudden 
cardiac death. The mechanism for how exactly the OSA causes 
the altered gene expression has not been fully elucidated, but it 
seems to be multifactorial, including stressors such has hypoxia, 
sympathetic stimulation, and increased intrathoracic pressure. 
Individuals who undergo treatment for OSA can reverse the 
pathologic alterations to the potassium ion channels and regain 
proper gene expression for potassium pumps that work cor-
rectly (Chahal, Somers, 2016, Bradley, Floras, 2003).
The risk of sudden cardiac death in patients with untreated 
OSA is not limited to extrasystole due to ion channel mal-
function. In fact, there are quite a few additional mechanisms 
by which sudden cardiac death may occur. For example, during 
REM sleep, there is a general increase in sympathetic stimula-
tion. (This is in contrast to other stages of sleep where the 
sympathetic nervous system is depressed.) The transition from 
non-REM to REM thus creates a situation which increases ox-
ygen demand. Experiencing an apnea, with the simultaneously 
occurring hypoxia, is thus of greater consequence at this point 
in the sleep cycle. This ensuing trauma to the heart can cause 
arrhythmias (Chahal, Somers, 2016).
Sudden cardiac death is of even greater concern in the 
morning hours because that is typically when the longest REM 
period takes place and because the apneas at this point tend 
to last for longer periods of time. In addition to the risk of 
arrhythmias being increased during this longer REM period, 
there is great risk of myocardial infarction or stroke at this 
point as well (Mooe, et.al. 2001). In general, blood pressure 
rises at different points in the sleep cycle. Individuals with 
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untreated OSA often experience an even greater increase in 
blood pressure- probably due mainly to the overstimulation 
of the sympathetic nervous system. The risk for MI or stroke 
is always increased with an increase in blood pressure, and as 
such, these individuals will be in the most danger during REM 
sleep. The longer REM and the prolonged apneas associated 
with it have claimed many lives (Michael Katzoff MD, personal 
communication May 2017).
Stimulation of the sympathetic nervous system can also result 
in tachycardia which further puts a large demand for oxygen 
on the heart at a time when the heart cannot get oxygen due 
the apnea. This situation can be even more life-threatening in 
patients with coronary artery disease (CAD) (Milleron, et.al. 
2004). Additionally, a myocardial infarction or stroke is often 
caused by a plaque rupture which is made more likely by the 
increase in blood pressure and also because of the intrathorac-
ic pressure caused by the obstructed airway (Chahal, Somers, 
2016). In fact, 43-91% of patients who experience a stroke also 
have sleep apnea (Leung, Bradley, 2001, Shamsuzzaman, et.al. 
2003). It is noteworthy that the rise in intrathoracic pressure 
has also been known to cause the rupture of an aortic aneurism 
which is typically fatal (Chahal, Somers, 2016).
In patients with pre-existing coronary artery disease (CAD) 
there is at least a 60-70% increase in sudden cardiac death or 
myocardial infarction when the individual also has untreated 
OSA. In addition to heart related problems there is an increase 
in cerebral vascular complications such as stroke. The cerebral 
vascular complications may result from the increase in the pro-
thrombotic effect connected with untreated OSA as well as 
from other factors effecting hemodynamics (Mooe, et.al. 2001, 
Peker, et.al. 2002). Fortunately, proper treatment for OSA has 
been shown to decrease the number of new cardiac issues or 
at least to dramatically slow the rate of coronary artery disease 
progression (Milleron, et.al. 2004, Peker, et.al. 2002, Jean-louis 
????????????????????????????????????????????????????? ????????????-
cial to cerebral vascular health (Gottlieb, et.al. 2010).
In general, the sympathetic system stimulation, which often 
lingers throughout the day in untreated OSA individuals, is 
known to increase platelet aggregation. This aggregation is detri-
mental to patients with CAD (Milleron, et.al. 2004). Additionally, 
???????????????????????????????????????????????????????????????-
????????????????????????????????????????????????? ??????????????
OSA, may be a risk factor in developing a deep vein thrombosis 
on top of the risk these factors pose to CAD (Milleron, et.al. 
2004, Bayram, et.al. 2009).
It is noteworthy that many patients with nocturnal angina 
experience relief when undergoing proper treatment for OSA. 
This suggests that the cause of pain, which is normally due to a 
lack of oxygen, is caused by the OSA and is effectively treated 
with standard CPAP therapy (Peker, et.al. 2002).
Another area of recent study is the possible connection 
between untreated OSA and dementia. One study found that 
the correlation between sleep apnea and dementia may be af-
fected by factors such as age, gender, and duration of the con-
dition. The mechanism for the connection between untreated 
OSA and dementia are not yet conclusive, but the connection 
between hypoxia, which is a side effect of untreated OSA, and 
neurological malfunction has been documented a number of 
times. For instance, rats which were exposed to hypoxic con-
ditions experienced a greater incidence of apoptosis in their 
hippocampus, and advanced brain imaging showed reduced grey 
matter in parts of the brain responsible for executive functions 
and memory. Damage to these areas in humans may be a factor 
in the cause of dementia (Svatikova, et.al. 2003, Ju, et.al. 2013).
????????????????????????????????????????????????????????????
conditions developed large amounts of cerebral amyloid plaque. 
Similar results have been found in humans with levels of serum 
amyloid A being two and a half times higher in patients with 
untreated OSA (Svatikova, et.al. 2003, Ju, et.al. 2013). Cerebral 
????????????????????????????????? ????????????????????????????????
?????? ???????????????????????????????????????????????????????????
phosphorylation of the tau proteins. Tau proteins are abundant 
in neural tissue and function in support of microtubules. When 
they are over-phosphorylated, they can malfunction and cause 
the structure of the cells in which they are found to become 
pathologically altered. Additionally, microtubules function as a 
sort of road or transport pathway for various particles within 
the cell.  The intracellular functions which rely on these trans-
port pathways may stop working properly if the tau proteins 
become over phosphorylated. Quite tellingly, another common 
?????????? ????? ????????????????????????????????????????????????
lab mice, cerebral amyloid plaque buildup and tau phosphor-
ylation has been connected to decreased memory function 
(Daulatzai, 2015). It is also possible that the general damage to 
the vasculature throughout the body due to hypoxia can be a 
factor in dementia because the vasculature in the brain is nega-
tively affected (Chang, et.al. 2013).
It has been shown that treatment of OSA in the early stages 
of Alzheimer’s disease can aid in dramatically slowing its pro-
gression. One study demonstrated that with treatment of OSA 
with CPAP machine, memory and mental processing speed im-
proved in any stage of dementia. Treatment also helped reduce 
?????? ???????????????????????? ????????????????????????????????
improvements experienced with CPAP treatment have had pos-
itive impact on patients with neurological illnesses. Conversely, 
some research indicates that the onset of mental decline may 
begin as much as one decade earlier in individuals with untreat-
ed OSA (Emamian, et.al. 2016).
Another connection between sleep apnea and brain function 
loss in humans is the presence of a common gene known as 
APOE4 (apolipoprotein epsilon 4) which has been shown to 
play a role in obstructive sleep apnea as well as being connected 
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to the development of dementia. The association could be a 
shared genetic fate, but it could also suggest that the gene is tied 
mainly to the development of OSA which, if left untreated, could 
lead to the damage which can cause dementia. Further studies 
would be necessary to determine the exact nature of the cor-
relation. The long-term effects of sleep deprivation caused by 
sleep apnea should be considered when determining the long-
term effects of untreated OSA on brain function (Chang, et.al. 
2013).
A recent study has implicated untreated OSA as one possible 
cause of Parkinson’s disease. The mechanisms seem most likely 
to include the general oxidative stress caused by hypoxia and 
??????????????????????????????????????????????????????????????
body’s response to untreated sleep apnea. There is even evi-
dence to support the possibility that the blood brain barrier 
may be interrupted as a result of cerebral vascular damage 
which may allow molecules harmful to brain tissue to cross the 
barrier and reach cells involved in Parkinson’s disease and other 
neurological pathologies (Sheu, et.al. 2015).
Conclusion
Extensive research reveals that untreated obstructive sleep apnea 
is extremely traumatic and damaging to the body. It has been 
clearly linked to physical diseases in the heart, brain, endocrine 
system, and vasculature, and it has been implicated as a cause for 
psychological and emotion distress, as well as secondary hazards. 
Mortality rates are consistently higher and earlier in individuals 
with untreated OSA and as such, individuals presenting to their 
??????? ????? ?????????? ????? ??????????? ??????? ??????? ???????????
with OSA should be tested for it. It is extremely important for 
health care providers to realize the severity of OSA and to un-
derstand that it can be present even in patients who experience 
few of the symptoms commonly indicative of OSA. Even patients 
with a relatively low AHI of about 4 or 5 are at risk because 
the trauma to the body is consistent and repeated every time 
the person sleeps, and this trauma has a tendency to have a cu-
mulative effect on the body. Early diagnosis is key because the 
negative effects of OSA can be eliminated with early treatment. 
Treatment should be adamantly encouraged even in individuals in 
whom permanent damage has already occurred because treat-
ment can reverse some of the damage and certainly help stabilize 
the patient and prevent the progression of further health issues. 
Unfortunately, the symptoms of sleep apnea are not always con-
nected immediately to the condition and are often written off as 
symptoms of other medical or phycological issues. It is therefore 
prudent of heath care practitioners to be mindful of sleep apnea 
and diagnose it as early as possible.
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